Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 679 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aura Biosciences, Inc.
Market Cap
$645.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$656.00M
Operating Margin
-383.15%
TTM Avg
-332.73%
3Y Avg
-228.44%
5Y Avg
-187.72%
Market Cap
$627.65M
Operating Margin
-4498.06%
TTM Avg
-5642.71%
3Y Avg
-2821.36%
5Y Avg
-1883.89%
Market Cap
$669.94M
Operating Margin
15.26%
TTM Avg
16.07%
3Y Avg
9.54%
5Y Avg
2.83%
Market Cap
$609.65M
Operating Margin
-12.47%
TTM Avg
-13.07%
3Y Avg
-26.14%
5Y Avg
-20.95%
Market Cap
$678.29M
Operating Margin
-187.24%
TTM Avg
-253932.81%
3Y Avg
-127981.70%
5Y Avg
-85456.42%
Market Cap
$685.23M
Operating Margin
317.06%
TTM Avg
-14996.68%
3Y Avg
-12629.31%
5Y Avg
-15360.40%
Market Cap
$604.13M
Operating Margin
40.10%
TTM Avg
33.30%
3Y Avg
-21.49%
5Y Avg
1.14%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aura Biosciences, Inc. (AURA) | $645.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Climb Bio, Inc. (CLYM)vs › | $642.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| OmniAb, Inc. (OABI)vs › | $656.00M | -383.15% | -332.73% | -228.44% | -187.72% |
| Prime Medicine, Inc. (PRME)vs › | $627.65M | -4498.06% | -5642.71% | -2821.36% | -1883.89% |
| MiMedx Group, Inc. (MDXG)vs › | $669.94M | 15.26% | 16.07% | 9.54% | 2.83% |
| AngioDynamics, Inc. (ANGO)vs › | $609.65M | -12.47% | -13.07% | -26.14% | -20.95% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $678.29M | -187.24% | -253932.81% | -127981.70% | -85456.42% |
| Helus Pharma Inc. (HELP)vs › | $685.23M | 317.06% | -14996.68% | -12629.31% | -15360.40% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $604.13M | 40.10% | 33.30% | -21.49% | 1.14% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $600.42M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
